Serina Therapeutics, Inc. Q1 FY2021 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2021 Q1 Call date: 2021-05-17 Concluded

Quarter scorecard

Revenue

$56,000

-37.1% YoY

Gross margin

94.6%

-4.3 pp YoY

Net income

Grant Revenues $46,000

Other Revenues $10,000